Improved Signs and Symptoms of Dry Eye Disease for Restasis^® Patients Following a Single Tearcare^® Treatment: Phase 2 of the SAHARA Study.

EDS also showed improvement after crossover; 46.48 at the cross-over visit (SD 24.80, median 48.00), 38.20 (24.86, 35.00; p = 0.003) three months later (study month 9), and 42.08 (26.23, 41.00, p = 0.129 ns) which did not reach statistical significance at six months after cross-over to TC ( Figure 1C ).

also in 111,027 other papers